Published Date : 2024-Jul-03
Myocardial Infarction Treatment Market Key Players Analysis: AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb (BMS), Novartis, Pfizer, Daiichi Sankyo, Bayer, Mylan, Apotex And More.
Myocardial Infarction Treatment Market Size, Share & Trends Analysis Report By Product Type (Beta-adrenergic blockers, Vasodilators, Angiotensin-Converting Enzyme (ACE) inhibitors, Angiotensin-Receptor blockers, Antiplatelet agents, Glycoprotein IIb/IIIa inhibitors, Antithrombotic agents, Analgesics, Thrombolytics), By Distribution Channel (Drug Stores, Online Drug Stores, Hospitals, Hospital Pharmacies and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America), Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast till 2028. (Intellectual Market Insights Research)?
According to a new report by Intellectual Market Insights Research on global Myocardial Infarction Treatment Market size was valued at USD 1535.50 Million in 2021 and is projected to reach USD 2363.15 Million by 2028.
Growing at a CAGR of 6.63% from 2021 to 2028.
Get Insight: https://www.intellectualmarketinsights.com/download-sample/IMI-000081
Industry: Pharmaceutical & Biotechnology
Website: https://astrazeneca.com
About Us: AstraZeneca is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England, UK and founded in 1999. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. Astra AB was founded in 1913 in Södertälje, Sweden and in 1993 the British chemicals company ICI demerged its pharmaceuticals businesses and its agrochemicals and specialities businesses, to form Zeneca Group PLC. Finally, in 1999 Astra and Zeneca Group merged to form AstraZeneca.
The company had approximately 89,900 employees, and it generated more than US$45.811 Billion in revenue in 2023.
Industry: Pharmaceuticals
Website: http://boehringer-ingelheim.com
About Us: Boehringer Ingelheim group was founded in 1885, the company is headquartered in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one. Unlike most large pharmaceutical companies which are listed, the company is private and fully owned by the Boehringer, Liebrecht and von Baumbach families. The company's key areas of interest are: respiratory diseases, metabolism, immunology, oncology and diseases of the central nervous system.
It operates globally with 146 affiliates and more than 50,000 employees and had revenues of €25.6 Billion in 2023.
Industry: Pharmaceuticals
Website: http://bms.com
About Us: Bristol Myers Squibb (BMS) is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, United States BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis, and psychiatric disorders.
It operates worldwide & employs over 34,100 (2023) people and had revenues of US$45.01 Billion in 2023.
Industry: Pharmaceuticals
Website: https://novartis.com
About Us: Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Founded in March 1996. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical companies in the world and was the fourth largest by revenue in 2022.
Novartis's revenue for 2023 was listed at US$45.44 Billion and company had nearly 75,500 employees.
Industry: Pharmaceutical Manufacturing And Biotechnology Research
Website: http://pfizer.com
About Us: Pfizer is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York. Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19 vaccine ($11 billion in 2023 revenues).
Employs over 88,000 people globally at 100+ locations worldwide and had revenues of US$58.5 Billion in 2023.
Industry: Pharmaceutical
Website: http://www.daiichisankyo.com
About Us: Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. Founded in 2005, the company is headquartered in Tokyo, Japan. The company owns the American pharmaceutical company American Regent. In 1990, Sankyo acquired the German Luitpold-Werk Group, a pharmaceutical company based in Munich.
The company had nearly 17,435 (2023) employees and had revenue of $ 9.44 billion.
